secwatch.observer — SEC 8-K summary
======================================

Issuer:     International Stem Cell CORP (ISCO)
CIK:        0001355790
Form:       8-K
Filed at:   2022-03-03T23:59:59+00:00
Accession:  0001564590-22-008509
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

International Stem Cell extends $2.9M CEO loan maturity to Sept 15, 2022
------------------------------------------------------------------------

- Extended maturity of $2.9M promissory note from CEO Andrey Semechkin to Sept 15, 2022 (was Mar 15, 2022).
- Note is unsecured, non-convertible, bears 4.5% annual interest.
- Loan originated Jan 13, 2022; this new note replaces the original on same principal.
- CEO Semechkin is Co-Chairman and CEO; transaction is a related-party financing.
- Company may prepay the note at any time without penalty.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1355790/000156459022008509/0001564590-22-008509-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1355790/000156459022008509/isco-8k_20220301.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-008509

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer